Skip to main content
OpenTrials

Clinical trial condition

Prostatic Hyperplasia

Explore clinical trials studying Prostatic Hyperplasia. Study availability and eligibility vary by location and protocol.

631 public trials 88 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Hyperplasia trial results

Completed

Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)

NCT00759135

Conditions
Benign Prostatic Hyperplasia (BPH), Enlarged Prostate, Genital Diseases, +5 more
Locations
  • Nymox Investigational Site Huntsville, Alabama, United States
  • Nymox Investigational Site Tucson, Arizona, United States
  • Nymox Investigational Site Little Rock, Arkansas, United States
  • Nymox Investigational Site Anaheim, California, United States
View all 30 locations
View Trial Details
Completed

Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia

NCT00077012

Conditions
Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • Raymond Fay, MD, Inc San Francisco, California, United States
  • George Washington University Medical Center Washington D.C., District of Columbia, United States
  • Advanced Research Institute Inc New Port Richey, Florida, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
View Trial Details
Completed

A Study of Tadalafil in Benign Prostatic Hyperplasia

NCT01183650

Conditions
Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munich, Germany
View Trial Details
Completed

Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH

NCT01260129

Conditions
Benign Prostatic Hypertrophy, Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • The Catholic Univ., Bucheon ST.Mary's Hospital Bucheon-si, South Korea
  • Busan National Univ. Hospital Busan, South Korea
  • Konkuk Univ, Chungju Hospital Chungju, South Korea
  • Choongnam National Univ. Hospital Daejeon, South Korea
View all 14 locations
View Trial Details
Completed

Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)

NCT00527605

Conditions
Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Wuhan, Hubei, China
  • GSK Investigational Site Nanjing, Jiangsu, China
  • GSK Investigational Site Hangzhou, Zhejiang, China
View Trial Details
Completed

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia

NCT00970632

Conditions
Benign Prostatic Hyperplasia (BPH), Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Adelaide, South Australia, Australia
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bentleigh East, Victoria, Australia
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bunbury, Western Australia, Australia
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nedlands, Western Australia, Australia
View all 44 locations
View Trial Details
Completed

A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia

NCT00793819

Conditions
Genital Diseases, Genital Diseases, Male, Lower Urinary Tract Symptoms, +8 more
Locations
  • Watson Investigational Site Huntsville, Alabama, United States
  • Watson Investigational Site Laguna Hills, California, United States
  • Watson Investigational Site San Diego, California, United States
  • Watson Investigational Site Aventura, Florida, United States
View all 27 locations
View Trial Details

Related conditions